Follow
Rahul Tiwari
Rahul Tiwari
Verified email at utrgv.edu
Title
Cited by
Cited by
Year
A review on albumin as a biomaterial for ocular drug delivery
R Tiwari, NK Sethiya, AS Gulbake, NK Mehra, USN Murty, A Gulbake
International Journal of Biological Macromolecules 191, 591-599, 2021
372021
Therapeutic challenges in ocular delivery of lipid based emulsion
R Tiwari, V Pandey, S Asati, V Soni, D Jain
Egyptian journal of basic and applied sciences 5 (2), 121-129, 2018
352018
Molecular determinants as therapeutic targets in cancer chemotherapy: an update
T Haider, R Tiwari, SP Vyas, V Soni
Pharmacology & therapeutics 200, 85-109, 2019
312019
Ocular self-microemulsifying drug delivery system of prednisolone improves therapeutic effectiveness in the treatment of experimental uveitis
R Tiwari, V Dubey, K Kesavan
Ocular Immunology and Inflammation 27 (2), 303-311, 2019
272019
Design and evaluation of ophthalmic delivery formulations
V Soni, V Pandey, R Tiwari, S Asati, RK Tekade
Basic fundamentals of drug delivery, 473-538, 2019
252019
Therapeutic potential of p53 reactivation in prostate cancer: Strategies and opportunities
S Kumari, V Sharma, R Tiwari, JP Maurya, BB Subudhi, D Senapati
European Journal of Pharmacology 919, 174807, 2022
222022
Cisplatin-loaded albumin nanoparticle and study their internalization effect by using β-cyclodextrin
R Tiwari, K Viswanathan, V Gour, SP Vyas, V Soni
Journal of Receptors and Signal Transduction 41 (4), 393-400, 2021
122021
State-of-art based approaches for anticancer drug-targeting to nucleus
R Tiwari, P Jain, S Asati, T Haider, V Soni, V Pandey
Journal of Drug Delivery Science and Technology 48, 383-392, 2018
112018
Critical parameters for design and development of multivalent nanoconstructs: Recent trends
AK Bakshi, T Haider, R Tiwari, V Soni
Drug Delivery and Translational Research, 1-24, 2022
102022
Toxicity and toxicokinetic considerations in product development and drug research
S Asati, V Pandey, V Gour, R Tiwari, V Soni, K Rajpoot, M Tekade, ...
Pharmacokinetics and toxicokinetic considerations, 401-424, 2022
82022
COVID-19 infection: targeting possibilities for treatment
T Haider, V Gour, V Pandey, IL Kanwar, R Tiwari, M Vishwakarma, ...
Critical Reviews™ in Therapeutic Drug Carrier Systems 38 (3), 2021
52021
Nanoparticles and skin cancer
V Gour, P Agrawal, V Pandey, IL Kanwar, T Haider, R Tiwari, V Soni
Nano drug delivery strategies for the treatment of cancers, 245-273, 2021
32021
One-step simultaneous liquid phase exfoliation-induced chirality in graphene and their chirality-mediated microRNA delivery
ENHK Ghali, N Chauhan, R Tiwari, M Cabrera, SC Chauhan, MM Yallapu
Materials Advances 4 (23), 6199-6212, 2023
12023
IN VITRO EVALUATION OF LECTINIZED CISPLATIN BEARING LIPOSOMES SYSTEM
R TIWARI, K VISWANATHAN, SP VYAS, V SONI
International Journal of Applied Pharmaceutics, 60-64, 2020
12020
Tabletized Nanomedicine: From the Current Scenario to Developing Future Medicine
R Tiwari, M Kolli, S Chauhan, MM Yallapu
ACS nano, 2024
2024
Engineered Inhalation nanoparticle formulation for lung cancer
R Tiwari, EN Ghali, N Chauhan, V Kashyap, SC Chauhan, MM Yallapu
Cancer Research 84 (6_Supplement), 2070-2070, 2024
2024
β-cyclodextrin-enzalutamide self-assembly complexes for prostate cancer therapy
M Kolli, R Tiwari, SC Chauhan, Y Zhang, N Chauhan, M Yallapu
2024
Nebulization based Inhalation Nanomedicine for Lung Cancer Treatments
R Tiwari, M Kolli, N Chauhan, EN Hanuma, V Kashyap, S Chauhan, ...
2024
Development of liposomes using microfluids for delivery of miR-205
V Herrera, R Tiwari, M Kolli, N Chauhan, ENH Kumar Ghali, SC Chauhan, ...
2024
Development of cross-linked tannic acid-based nanoparticle for lung cancer treatment
R Tiwari, VK Kashyap, ENHK Ghali, SC Chauhan, MM Yallapu
2024
The system can't perform the operation now. Try again later.
Articles 1–20